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The carcinogenicity ofchromium compounds is reviewed with specific attention to the gaps in
knowledge for risk estimation and research needs. The most important problems at present are
whether trivalent chromium compounds cause cancer, and whether there is a difference in
cancer causing effects between the soluble and the slightly soluble hexavalent compounds in the
practical exposure situation. Dose estimates for risk estimation based on epidemiological
investigations are also lacking.
Present evidence indicates that the trivalent chromium compounds do not cause cancer
although high concentrations in some in vitro systems have shown genetic toxicity. Hexavalent
chromium compounds cause cancer in humans, in expernmental animals and exert genetic
toxicity in bacteria and in mammalian cells in vitro. Epidemiological evidence and animal
experiments indicate that the slightly soluble hexavalent salts are the most potent carcinogens,
but proper identification and charactenrzation ofexposure patterns in epidemiological work are
lacking. Workersalsotend to have mixed exposures. Soluble andslightly soluble salts are equally
potent genotoxic agents in vitro.
Further work for establishing dose estimates for risk evaluation in epidemiological work is
important. In vitro systems should be applied for further identification of the mechanism of the
carcinogenic effects, and animal experiments are urgent for comparison of the careinogenic
potency of the different hexavalent salts. Hexavalent chromium salts must be regarded as
established carcinogens, and proper action should be taken in all industries with regard to such
exposure. At present the carcinogenic risk to the general population caused by chromium
compounds seems to be negligible, chromium in cigarettes, however, is an uncertainty in this
respect. The amount ofchromium and the type ofchromium compounds inhaled from cigarettes
is not known.
ral toxicology of chromium compounds differences in cancer causing effects between solu-
.viewed by the National Academy of ble and slightly soluble salts ofhexavalent chromi-
and by the National Institute of Occu- um. The specific compound or compunds which
'ety and Health (2). The careinogenic have caused cancer in chromate workers are not
of chromium compounds have been known, and an important problem is also the lack of
reviewed by the International Agency adequate dose registration for dose-response eval-
h on Cancer (3). More recently, several uatioons and risk estimation. The importance of
-eviews of the toxicology of chromium smoking in chromium carcinogenesis is not known.
ablished (4-8), and possible mechanisms
ogenic effect have beenreviewed based Chemistry-Biological Interactions
evelopments in in vitro tests (9-11).
r does not present an extensive histori- Chromium is a transition metal with an atomic
of the carcinogenicity of chromium. weight of52. The most common valences are 0 +2,
s which are important for discussing +c3, and +6. The only important chromium ore is
gaps in knowledge of the carcinogenic chromite, FeOCr2O3. Chromates are produced by a
gromium are presented. The most im- smelting, roasting and extractionprocess. Soda ash
lems at present pre wheTher trivalent or soda ash and lime are reacted with chromite.
auses cancer, and whether there are With the soda ash method, sodium chromite is
fonned, and this substance issubsequently oxidized
to sodium chromate and extracted. The lime meth-
cutonalzHealth,Gydasvei8,Oslo3, Norway. od formscalciumchromate/chromite complexes which
1981 121are insoluble in water but soluble in acid. The
residue from both processes contains an unknown
mixture of mostly insoluble chromium compounds
(12). In the ferroalloy industry and for refractory
work, chromites areused, andonlylimitedamounts
ofhexavalent chromium compounds are assumed to
be present. Chromium metal is produced from
chromates by reduction.
Both trivalent and hexavalent chromium are
found in nature, but the trivalent is the more
common form. Divalent chromium compounds wrill
oxidize unless protected from air. Chromium in
biological materials is probably always trivalent
(13). When animals are exposed to hexavalent
chromium, the hexavalent fonn exists for some
time indicated by a different distribution pattern
than after exposure to the trivalent form (4). After
some time only trivalent chromium is found. When
added to tissue in vfitro, the reduction takes place
withinminutes(14). Theso-calledglucosetolerance
factor, which has not been fully identified, is a
trivalent chromium complex with niacin (15). The
trivalent chromium ion has a strong tendency to
form coordination complexes and chelates in aque-
ous solutions and does not exist in the free form
(Table 1). Water may serve as a ligand, but in
complex solutions water may be replaced by other
anion (halides, sulfates, organic acids). Underalka-
line conditions, foming ofpolynucleate complexes
which may precipitate due to a replacement of
water with OH- takes place (13).
The hexavalent form of chromium is almost
always linked to oxygen and is a strong oxidizing
agent (Table 1). The hexavalent form is readily
reduced to the trivalent form by contact with
organicmatter. Oxidationoftrivalentchromium(or
chromium metal) to the hexavalent form in organic
matter seems unlikely (13).
Table 1. Identity and solubility of
Hexavalent chromium readily passes the e
membrane while the trivalent form does not seen
to have this property (13, 16). Once in the cell, the
hexavalent form is reduced to the trivalent. The
site inthe cellforthis conversionhas been suggest.
edtobeboththeplasmamembrane, theendoplasrnic
reticulum, the mitochondria or the cell nuclew (17-20). The biological effects of the hexavalent
form may thus either be related to the reduction
process, to the subsequent binding ofthe trivalent
chromium to macromolecules, or possibly to both.
Trivalent chromium complexes with a number of
ligands within the cell. High concentration ofchro.
mium is normally found in nucleic acids (21). Its
function, if any, is not known, but a stabilizing
effectofchromium on RNA hasbeendemonstrated
in vitro (22). Chromium in RNA may be in an
organic form; orgnochromium in compounds of
toxicological significance has not been described,
but chromium carbonyl causes cancer in a trans-
plantation animal technique (23).
Environmental Exposure
Chromium exposure to the general public has
important health consequences because of its skin
sensitizing effect. Chromium is among the most
common sensitizers in allergic eczema (24). The
daily intake from food has been estimated to be in
the range of 0.03-0.1 mg (1, 4). The chromium
content in municipal drinking water has been esti-
mated tobe inthe same range asin riversand lakes
(1-10 limgll.), occasionally somewhat higher (1).
Urban air concentrations have been reported from
less than 10 ng/m3 to about 50 ng/m3, for rural
stations seldom above 10 ng/m3 (1). A possible
source ofchromium exposure to the general public..
is waste dumps for chromate-producing plants
some chromium compounds."
Compound Formula Valence Aqueous solubiity
Chromium Cr 0 Insoluble
Chromium acetate Cr(COOCH3)3 *H20 3 Soluble
Chromium carbonate Cr203 0 C02 4H20 3 Slightly soluble
Chromium phosphate CrPO4 3 Insoluble
Chromic oxide Cr203 3 Insoluble
Calcium chromate CaCrO4 6 Slightly soluble
Chromium trioxide (chromic acid) CrO3 6 Soluble
Lead chromate PbCrO4 6 Insoluble
Potassium dichromate K2Cr207 6 Soluble
Potassium chromate K2CrO4 6 Soluble
Sodium dichromate Na2Cr2O7 6 Soluble
Sodium chromate Na,CrO4 6 Soluble
Barium chromate BaCrO4 6 Insoluble
Strontium chromate SrCrO4 6 Insoluble
Zinc chromate hydroxide Zn2CrO4(OH)2* H20 6 Slightly soluble
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Tobacco has been reported to contain up to about
mg/kg of chromium, but most values are re-
rted to be low 5 mg/kg (25). No estimates ofthe
ed amount orofthechemicalfornmofchromium
tobacco smoke have been found. With the possi-
exception of chromium in tobacco, where fur-
iernvestigations are needed, no associatiol has
t been made between chromium exposure to the
neral public and human ancer.
coupational Exposure
Potentiallyhazardous exposuretochromiumcom-
poundsmaytakeplaceinthemetalrefining/chromate
uction industry, in the metallurgic industry
and in the refractory brick industry. Hazardous
chromium exposure is also reported in industries
which are secondary users of chromium chemicals
n pigments production and plating. Welders and
grinders in the secondary metal industry (steel
weldingandgrinding, anticorrosive paints) are also
exposed to chromium compounds, and chromium
may be found in small amounts in a variety of
industrial settings (catalysts in chemical industry,
paintproductionanduse). Chromium isextensively
in tanning (2).
Mancuso and Hueper (26) and Mancuso (27)
Wrported exposure levels of up to i mg/M3 in a
chromate producing plant, but most values were in
the range of 0.26-0.52 mg/m'* A five-shift mean
value of 1.35 mg/m3 for a sack filling operation was
eported by Langard and Norseth (28) in an old
~chromate pigment plant, while in another modern
Wlant levels were mostly below 0.2 mg/m3. In a
0 ferrochromium plant most average shift values
(personal sampling) were below 0.05 mg/m3, but
occasional values up to 1.3 mg/m3 (total chromium)
,.were recorded (29). In a recent review a chromium
posure up to 5mg/m3 in the plating industry was
mentioned, but most values were in the range
0.1-0.2 mg/i3 (2). Similar values for chromium
,exposure im different industries have been indicat-
Ped in a review by Hayes (30). The exposure levels
seem to havebeen fairlyconstant duringthe last 20
N.years in olderplants, but lower values are found in
new plants.
Epidemiological Studies
The epidemiology ofcancer in chromium exposed
workers hasrecently been reviewed by Hayes (30).
sgf Even if the first cases of cancer were described in
g.,secondary users ofchromates (30), the most exten-
.sive epidemiological results stem from the chro-
mate producing industry. An inereased risk of
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respiratory cancer in this industry has been
irrefutably established from a numberofcountries.
Inareviewpaperfrom 1950, Baetjer(31)deserbed
109 cases of cancer in the chromate producing
industry, 11 cases in the chrome pigment industry
and 2 cases im other industries. Already in 1936
German health authonrties recognized lung cancer
as a possible occupational disease associated with
chromate dust exposure. Other papers reviewing
the numberofcases indifferent countries have also
appeared (6, 22-34). Mostcases have beenreported
from the chromate production industry, but also
reports from the chrome pigment industry have
appeared (28, 35).
Hueper(36)reviewedthehistologicalclassification
of123 casesoflungcancerinchromate workersand
found 46 squamous cell carcinomas, 66 anaplastic
types and 11 adenocarcinomas. Great vanrations
have been reported for the period from the first
exposure to chromates and the diagnosis ofcancer
(6). A time period as long as 47 years has been
found, mean value from different authors seems to
be about 20 years with observed to expected ratios
ofup to about 40. Cancer ofthe nasal cavities has
been reported in chromate workers, as well as
laryngeal cancer (6).
Mancuso (27) and Mancuso and Hueper (26)
stated in 1951 that inhalation of chromite ore dust
characterized as insoluble chromium might be an
important factor in the production of lung tumors.
None of their lung cancer deaths were found in
workers exposed predominantly to soluble chromi-
um compounds (hexavalent). Mancuso (37) recently
published a followup of this group and stated that
both exposure to trivalent and hexavalent chromi-
um constitute a cancerrisk. Theoriginal group was
divided into workers exposed to predominantly
insoluble or soluble compounds. Mancuso found
that the lung cancer death rates increased by a
gradient level of exposure both to insoluble and to
total chromium. None of the groups had exclusive
exposure to either type of compund. There is no
information about a possible gradient exposure to
soluble (hexavalent) compounds in the group ex-
posed mainly to iMsoluble compounds. Nor is there
information about agradient exposure to insoluble,
nor to slightly soluble hexavalent compounds in
either group. The simiklAr increased risk in both
groups as estimated from the death rates may
indicate that such exposure is reasonable. If not,
trivalent chromium should be an equally potent
carcinogen as are the hexavalent compounds.
In a report by the United States Public Health
Service the exposure pattern for 10 cases of lung
cancerbased onweighted avterage exposures byjiob
classification has been reported (30). A low risk was
123contributed to chromite exposure and to exposure
to soluble compounds. It was concluded that expo-
sure to acid-soluble, water-insoluble compounds in
the roast and residue constituted the excess nrsk.
Mostepidemiologicalreportscontainnoclassification
of exposed workers to specific jobs or exposure
patters, but in a recent paper, Hayes (38) indi-
catesthatthe highrisk isrelated to the "wet" part of
the proces where mainly watersoluble hexavalent
compounds are handled. The authorstates, howev-
er, that most workers had not been exclusively
employed in a single part of the plant.
The major secondary use of chromium is in
chromate pigment production, in the plating indus-
try and for taining. Gross and Kolsch in 1943 (39)
reported 8 cases from the pigment-producing in-
dustry, and Baetjer (31) reported 11 cases, but
some of the latter had been reported before. An
increased risk of respiratory cancer was demon-
strated by Langard and Norseth (28) (riskratio 38)
in apigment-producingplant, butthe riskestimate
wasonlybased on three cases. Assuming a Poisson
distribution, theinreasedriskis, however,significant
atthe0.05level. Theworkers wereexposed tolead
and zinc chromate at levels up to 1.35 mg/im3 as
chromium. In a surveyofU.S. pigment plants (40),
anincreased risk wasfound forworkers exposed to
both zinc and lead chromate, and a corresponding
increasedrisk wasfound forworkers with exposure
classified as high for lead and zinc chromates by
Davies (35). Maltoni (41) has reported 21 cases of
lungcarcinoma in a groupof200chromium pigment
workers. Cytological examinations were performed
on a group of 116 workers and the incidence of
abnormal cells (class III-VI Papanicolaou) was
about25% as compared to6% in the PVC industry,
1.6% in the chemical industry in general, and 0.6%
in heavy smokers.
Of specific interest for the evaluation of soluble
versusinsoluble, orslightly soluble, chromate com-
pounds as cancer causing agents is the cancer risk
in the plating industry because of the uniform
exposure to soluble compounds. Royle (40, 41)
compared a population ofplaters exposed to chro-
mium (VI) oxide to areference population matched
with respect to age, sex and smoking habits. He
analyzed 246 certified causes ofdeath and found a
higher number of malignancies than expected for
lung and pleura, for gastrointestinal tract and for
other unspecified sites, but only total deaths from
malignant neoplastic disease were significantly in-
creased (51 compared to 24 expected, significant at
the 1% level). Waterhouse (43) in a preliminary
communication, found total deaths from malignant
disease above expected number 'in a population of
chromium platers, but the difference was not sta-
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tisticallysignificant. He found, however, 49 deaths
from lung cancer among male employees compared
to 34.88 expected (p < 0.05). The significance of
thesereportsis uncertain. OkubaandTuschiya(44)
have reported the results from an epidemiological
study of 589 plating firms in Japan. No increased
risk for respiratory cancer was found, but the
conclusions areuncertain becauseofshortobserva-
tion time and a high loss (10%) to follow up. If
exposure to hexavalent chromium in the plating
industry constitutes a cancer risk, the risk is
certainlymuchlessthaninthechromate producing
or in the chrome pigment industry with the expo.
sure levels which have been prevailing in these
industries for the last 20 years.
Noepidemiologicalinvestigationshavebeenpub-
lished forthe large group ofchrome pigment users
mvariousotherindustries, butbasedonexperience
from pigment production, these workers must be
regarded as being at risk if there is a significant
exposure. A large group with a possible risk is
welders and gnnders exposed to welding aerosols
fromstainless steelorfromworkingwithchromate
primed materials. With stainless steel welding,
about 70% ofthetotalchromium inthe aerosol isin
thehexavalentfonnassolublesodiumorpotassium
monochromates (45), and fume particles have been
shown to be mutagenic (46). Both the relative
amount of hexavalent and the solubility of these
salts seem, however, to vary with the type of
welding (47, 48). Exposure levels for total chromi-
um up to 1 mg/i3 as chromium havebeen reported
forwelders (47, 49, 51). In arecent epidemiological
investigation of workers in a ferrochromium plant
Langard (29) reported a suspect increase of
respiratory cancer. Cancer incidence among 976
workers employed before 1960 and employed in
ferrochromium or ferrosilicon production was in-
vestigated. Nine casesoflungcancerwerefound in
the total population, seven in the subpopulation of
325 employed in ferrochromium production. The
expected number of respiratory cancers was 3.1
and 1.8 usingnational and local expected incidence
rates, respectively, and less than 1 compared to an
internal reference popula'tion. Dust concentrati'ons
(total chromium) ofup to 1.3mg/r3, wererecorded
at the time of the survey, from 11 to 33% were
water-soluble components. Axelson (50) could not
demonstrate anincreasednrskofrespiratorycancer
in a corresponding investigation, but theindustrial i
process mn this case did not produce significant
amounts ofhexavalent chromium compounds (solu-
ble). Pokrovskaya(49)reported increasedincidence
ofrespiratory cancer in workersemployed in ferro-
chromium production. Also othercarcinogenswere,
however, present [benzo(a)pyrene, hexavalent chro-
Environmental Health Perspectives:urT]. Only one inconclusive report has been
blished from the refactorvy brick industry (30).
o reports have been found from the tanning
'The possibility that exposure to chromium com-
undsmight cause cancer at othersitesthanin the
piratorytract isamatterofdiscussion. Based on
ye es of cancer observed in a small group of
mate workers, Teleky (52) suggested a rela-
ihipbetween exposure tochromatesand cancer
the gastrointestinal tract. Taylor (53) reported
trointestinal cancercases tobeslightlyinexcess
similargroup. In the surveyof3 U.S. chromate
igent plants, an increased risk ofgastric cancer
found in one plant (54). A slight increase in the
Fumber ofcancers in the gastrointestinal tract has
so been reported in chromium electroplaters
0,42). Langard and Norseth (55), in a followup of
e previously reported cohort from a pigment
lant found three cases ofgastrointestinal cancerin
smallsubpopulation of24 workers with more than
e years ofemployment by the end of 1972. The
umbers are too small for final conclusions. Also in
e ferrochromiun plant referred to previously, a
ggested increase risk of gastrointestinal cancer
was found. Among the 325 ferrochromium workers
n the survey, five cases of gastnrc cancer were
eported compared to 3.18 expected (29).
Animal Experiments
A review of animal data up to 1972 has been
published by the International Agency for Re-
earch on Cancer (3). The results support the
nassumption that the most potent carcinogenic chro-
compounds are the slightlysoluble hexavalent
ts, specifically calcium chromate. This compound
is carcinogenic by tracheal instillation, and by
gintramuscular and intrapleural injection. Calcium
thromate is the only chromium compound which
has given respiratory cancer after inhalation in
,1an imalexperiments (56), although tests in progress
with suggested positive results have been reported
forunspecified mNtrmediates fromchromateproduc-
-tion (30). Instillation experiments with soluble
1:chromates have given negative results, and the
same is reported for inhalation experiments WIth
..such compounds (3).
Using the tracheal implantation technique of
dLaskn (57,57), Levi(59)demonstrated acarcinogenic
"'effect of calcium chromates. Also zinc chromate
gave positive results. One cancer was reported in a
,..group of100 rats exposed tochromicacidcompared
-to 8 with calcium chromate and 3 with zinc chro-
mate. The chromic acid results should therefore be
-regarded with some caution. Implantation of chro-
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mic chromate alone did not give any cancers, but
after the dispersion ofthe same substance im silica,
three cancers were found. No explanation is given
for this result. Intermediates from chromate pro-
duction have also been shown to be carcinogenic in
tracheal implantation and possibly as mentioned
after inhalation (30, 60). The specific active agent
cannot be identified in the latter experiments.
In Vitro Studies
Important recent developments in the under-
standing of chromium carcinogenicity have come
fromthestudyofmutagenic activity inbacteriaand
from work with isolated cell systems. Metals as
mutagens have recently been reviewed by Flessel
(10), and Sunderman (11) hasrevi'ewed the effectof
metalsongeneticmaterialboth inisolatedbiochem-
ical systems, in microbiological systems and in in
vitro cell systems.
Chromates are mutagenic inEscherichia coli and
in Salmonella typhimurium (60-72) and influence
DNA repairinBacillus subtilis (69, 73). Venittand
Levi (60) and Petrilli and de Flora (62) in a
comparative study found no significant differences
in dose-response between the soluble and slightly
soluble compounds in either the Salmonella or the
Coil system. Chromates seem to be directly acting
mutagens as noactivation bymicrosomefractionsis
necessary. De Flora (19), on the contrary, found a
deactivation ofsodium dichromate as a mutagen in
the Salmonella system by adding liver microsomal
fraction. This has been confirmed by Lofroth (18)
and PetriUi and de Flora (67). Nishioka (73) found
that the mutagenic effect disappeared when the
hexavalent salts werereduced tothe trivalent form
in the experimental system using sodium sulfite.
Oxidation ofthe trivalent form to the hexavalent in
the test system, on the other hand, increases the
activity (68). Trivalent chromium salts seem in
general tobe withoutorwithavery weakmutagen-
ic activity in bacterial systems.
Ofparticular interest is a theory set forward by
Lofroth (18) that the causative agent in chromium
mutagenesis istrivalentchromiumbound togenetic
materialafterreduction ofthehexavalentformby a
NADPH dependent microsomal enzyme system.
The decrease in activity reported by the reduction
ofthe hexavalent form tothetrivalentform (19, 66,
73), mightthen be explained by a decreased uptake
of the trivalent form by the cells.
Potassium dichromate is mutagenic in yeast (74),
and soluble hexavalent salts induce morphological
transformation and chromosomal aberrations in
manunalian cells in vitro (69, 75-81). Chromosomal
aberrations are also found in workers engaged in
125chrome production (82). Nakamuro et al. (69) found
that both hexavalent and trivalent soluble salts had
this effect, but the hexavalent salts were the most
potent. Newbold et al. (79) could not, however,
demonstrate effects of lead chromate (insoluble
hexavalent). Soluble trivalent salts had no such
effect (79, 80). In hamster embryonic cells the
effect of potassium dichromate disappeared when
chromium was reduced to the trivalent form in the
experimental system (77). Sirover and Loeb (83)
found increased error frequency in DNA synthesis
in vitro with both trivalent and hexavalent chromi-
um with a 30% error with chromiumconcentrations
of0.64mM(trivalent)and 16mM(hexavalent). These
results support the trivalent form to be the active
agent atthesite ofaction. Trivalent chromium salts
have also been shown to give positive results in
other experimental model systems by altering the
physiochemicalpropertiesofmacromolecules(84-87).
Various chromium compounds may influence the
metabolismofgeneticmaterials (88-93). Leviset al.
(88-91) claim, based on studies of DNA/RNA syn-
thesis inhamsterfibroblasts (BHKline) and human
epithelial-like cells (HEp line), that the hexavalent
form is reduced by passing the plasma membrane,
but assume that trivalent chromium is the active
agent within the cell. Both the soluble hexavalent
and trivalent salts decreased the DNA synthesis,
but after adding either form only the trivalent was
found inside the cells. The necessary concentration
was a 100 times higher for the trivalent forn than
forthe hexavalent fonntogetaneffect. Hexavalent
chromium first stimulated nucleoside uptake bythe
cells, then -inhibited the uptake; amino acid uptake
was only inhibited. The trivalent form had no such
effects (91, 92). Also an effect ofpotassium dichro-
mate on mitosis in mammalian cells has been
demonstrated (93).
Evaluation of Present State of
Knowledge;
Chromium as the glucose tolerance factor has an
essential function in humans. High concentration of
chromium is found in RNA and a stabilizing func-
tion of chromium has been suggested. Only the
hexavalent and the trivalent chromium compounds
have biological importance. The hexavalent form is
a strongoxidizingagent and is almost always found
together with oxygen. The hexavalent form is
rapidlytransformed tothe trivalent form in contact
with organic materials. Hexavalent chromium salts
readily pass biological membranes, trivalent chro-
mium does not seem to do so. Once in the cell, the
hexavalent form is rapidly reduced to the trivalent
126
form. The biological effects ofchromium, including
the carcinogenic effect are results of this transfor.
mation, subsequent bindingofthe trivalent form to
ligands within the cell or both. The trivalent fornm
hasastrongtendencytoformcoordinationcomplexes
and chelates in aqueous solutions, it may precipi-
tate at physiological pH because of polynucleate
complex formation with OH- ions.
An increased risk ofrespiratory cancer has been
irrefutably established forworkers in thechromate
industry. A corresponding risk has been shown in
the chromate pigment producing industry. An in-
creased risk of respiratory cancer has not been
conclusively established in ferrochromium produc-
tion, in the refractory brick industry or in the
plating industry. Secondary users of chromate
pigments, including welders and grinders, must be
regarded as being at risk on theoretical grounds,
but epidemiologically an increased risk of cancer
has neverbeen shown. Thenumberofepidemiolog-
ical investigations are, however, limited for all
groups except for workers in the chromate produc-
ing industry. An increased risk of cancer at other
sites than the respiratory tract (gastrointestinal
tract) has been suggested, but not finally estab-
lished.
Negative results from the plating industry indi-
cate that soluble chromates either do not cause
cancer or are less potent carcinogens than slightly
soluble compounds (calcium chromate). Based on
results from the chromate producing industry is it
not possible to either verify or dismiss this theory
because of insufficiently described exposure pat-
terns. Because of analytical procedures, slightly
soluble compounds seem mostly to be regarded as
trivalent. This may not be correct as also slightly
soluble hexavalent salts may be present in the
workingenvironment(calcium-zinc-leadchromates).
Animal experiments supportthe assumptionthat
the slightly soluble hexavalent salts (calcium chro-
mate) are the active agents, but inhalation expen-
ments are few. Tracheal instillation experiments
are, however, highly suggestive that this is the
case. Soluble and slightly soluble hexavalent salts
(calcium chromate) are equally potent for causing
mutations in bacterial systems, and both soluble
and slightly soluble salts cause chromosomal dam-
age or cell transformation in isolated celLs. Triva-
lent chromium may cause mutation and cellular
transformation in titro in high concentrations. The
differences in activity of the soluble and slightly
soluble hexavalent salts in the practical exposure
situation may be related to retention time on the
mucous membrane in the respiratory tract, to a
time/concentrationfactorcausedbyslowsolubilization
and removal, or to differences in the intracellular
Environmental Health Perspectivestics of the two differentt classes of compunds.
ere is at present no epidemiological evidnece
.trivalent chromium to be carcinogenic. Epide-
logical evidence is supported by animal experi-
ts and particularly by in intro results and
emical considerations. When tested in sys-
whichrequirethatchromiumpassesbiological
branes to exert an effect, reduction of the
valentformtothetrivalentreducesorabolishes
effect. Similarly, trivalent chromium which is
hout effects im such systems when oxidized to
e hexavalent form in the system has genotoxic
kets. The trivalent form has a more potent
otoxic effect than the hexavalent in systems
thoutbiologicalmembrnes, andasthehexavalent
is rapidly reduced in contact with biological
terial, theactivesubstance atthe siteofactionis
bably the trivalent form. There is no agreement
to in what part of the cell this reduction takes
e, probably at several sites. Itis neitherknown
what extent the effects caused by hexavalent
~hrouum are directly related to the reduction
pocess or to the subsequent binding of the trnva-
ent form. Available evidence indicates, however,
tat the mechanism of chromium carcinogenicity
fvolves a direct interaction oftrivalent chromium
with genetic material or genetic processes, though
bdirect interaction by virus or other chemical
iubstances has been suggested (95-97).
No risk estimation of cancer in workers exposed
o chromium in the chromate producing industry
ased on reliable dose-response information is pos-
abe at present. Some exposure data have been
,ecorded, but the chemical characterization ofdata
n the very complex exposure situation in the
hromate producingindustry is insufficient. A com-
gicatingfactor is that most workers have probably
i more than one job. It should, however, be
ioted that even ifthere are relatively few investi-
rationsreported from the plating industry, refrac-
ory brick industry and ferrochromium industry,
he risk ofcancer must have been less than in the
bromate producing industry and in the chrome
pigment industry with the exposure levels which
ave been prevailing for the last 20 years. Levels
.r exposure and risk cannot, however, be estab-
hshed.
3aps in Knowledge and Research
4eds
Chromium carcinogenesis is in good accordance
with the somatic mutation theory for cancer, but
why and how the mutant cell develops into a cancer
s as for other chemical carcinogens, not known.
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Once this has been mentioned, the most important
gaps in our knoweldge are data for risk estimation
based on dose-response for specified industrial
processes or for specific chromium compounds.
This problem calls for research with model sys-
tems and for further epidemiological research.
Furtherstudiesonthemechanism ofthecarcinogenic
action is necessary for the evaluation of the
interrelationship between the trivalent and hexa-
valent form in carcinogenesis. It is not known if
trivalent chromium might penetrate the biological
membrane under specific ci'rcumstances. Animal
experiments with defined chemical compounds of
chromium are urgently needed. Specifically the
relationship between soluble and slightly soluble
compunds should be evaluated in such systems.
This problem is difficult to solve in epidemiological
investigations because of the mixed exposures in
many industries. Inhalation or intratracheal
instillation should be the preferred methods.
Further epidemiological investigations should be
started in all populations where exposure to chro-
miumtakesplace. Notonlycancerintherespiratory
tract should be looked for, a possible increased
incidence of cancer in all organ systems should be
investigated. Cancer in the gastrointestinal tract
may be ofparticular interest. This is also the case
for exposure to trivalent chromium. Mixed expo-
sure with smoking is an important problem in risk
estimation. The amount of chromium inhaled from
cigarettes, and the chemical form are not known.
At present we have recorded an increased num-
ber of workers with cancer in some high risk
groups. It is unrealistic to assume that low risk
groups may be evaluated in a similar way. For low
risk estimation both in epidemiological work and
when using experimental animals, the necessary
number of individuals under study soon becomes
prohibitive.
Extrapolation from high exposure in relati'vely
small groups for short time periods to low level,
long-time exposure in large groups for a disease
like cancer is hazardous.
Recent developments in applying model systems
for mutagenicity studies are promising for evalua-
tion ofthe mechanisms ofcancer caused by metals.
Furthermore, epidemiologic studies should berefined
with a more detailed work history for the exposed
groups. This is difficult for retrospective studies,
especially for metal carcinogenesis. Care should be
taken to record relevant dose-indicators for pro-
spective and for retrospective work. Intemnational
collaboration in epidemiological work should be
encouraged to inerease the size of the exposed
groups, and registration of workers and exposure
levels should be introduced in industry as recoi-
127mended by ILO (98). Epidemiological follow-up of
the benefits ofearly diagnosis is important. Early
diagnosis must, however, not be sold as a cure for
industrial cancer.
Lastly, let us not forget that even if there are
definitegapsinourknowledgein chromium toxicol-
ogy, our knowledge is sufficient for us to work for
an improvement of the worldng conditions where
excessive and unnecessary,exposure to chromium
takes place in our iMdustry, or in the general
environment. Thus, epidemiological investigations
asrecommended arenotnecessaryforprovingthat
some chromium compounds cause cancer, but they
areneeded forestimatingamaximumriskbased on
inevitable exposure ofpopulations at hand.
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